IIPR

The past six months saw several events impacting IIPR's stock price. Ongoing tenant defaults and resolutions, including those with PharmaCann, Cannabist Company, Battle Green Holdings, and Parallel, have been a persistent challenge contributing to stock volatility. The company reported mixed second-quarter 2026 earnings with slight revenue growth but missed consensus estimates, though Adjusted Funds From Operations supported dividend coverage. IIPR announced a $245 million mezzanine loan commitment for Alewife Park, a life science campus in Cambridge, MA, as part of its diversification strategy. It also priced a public offering of 2 million shares of preferred stock to raise $50 million for life science commitments and general corporate purposes. Macroeconomic headwinds, such as rising Treasury yields, have pressured rate-sensitive REITs, and concerns about the sustainability of IIPR's dividend due to a high payout ratio have been noted.